A detailed history of Comerica Bank transactions in Vericel Corp stock. As of the latest transaction made, Comerica Bank holds 191,975 shares of VCEL stock, worth $10.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
191,975
Previous 192,478 0.26%
Holding current value
$10.5 Million
Previous $8.83 Million 8.15%
% of portfolio
0.03%
Previous 0.04%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$42.25 - $53.56 $21,251 - $26,940
-503 Reduced 0.26%
191,975 $8.11 Million
Q2 2024

Aug 15, 2024

SELL
$41.71 - $52.9 $983,605 - $1.25 Million
-23,582 Reduced 10.91%
192,478 $8.83 Million
Q1 2024

May 15, 2024

BUY
$32.52 - $52.33 $500,027 - $804,626
15,376 Added 7.66%
216,060 $11.2 Million
Q4 2023

Feb 14, 2024

SELL
$30.85 - $37.09 $243,252 - $292,454
-7,885 Reduced 3.78%
200,684 $7.15 Million
Q3 2023

Nov 21, 2023

BUY
$31.69 - $39.25 $6.6 Million - $8.17 Million
208,228 Added 61063.93%
208,569 $6.99 Million
Q2 2023

Aug 22, 2023

SELL
$29.0 - $38.37 $6.72 Million - $8.89 Million
-231,812 Reduced 99.85%
341 $0
Q4 2022

Jan 26, 2023

SELL
$17.65 - $27.37 $166,668 - $258,454
-9,443 Reduced 3.91%
232,153 $0
Q3 2022

Oct 28, 2022

SELL
$22.62 - $32.54 $73,650 - $105,950
-3,256 Reduced 1.33%
241,596 $5.91 Million
Q2 2022

Aug 02, 2022

BUY
$22.88 - $39.45 $114,011 - $196,579
4,983 Added 2.08%
244,852 $6.92 Million
Q1 2022

Apr 27, 2022

BUY
$31.69 - $43.29 $2.22 Million - $3.03 Million
69,947 Added 41.16%
239,869 $9.17 Million
Q4 2021

Feb 18, 2022

SELL
$35.2 - $52.6 $3.74 Million - $5.59 Million
-106,185 Reduced 38.46%
169,922 $6.68 Million
Q3 2021

Nov 22, 2021

BUY
$46.35 - $59.75 $7.95 Million - $10.2 Million
171,516 Added 163.99%
276,107 $13.5 Million
Q2 2021

Aug 26, 2021

BUY
$47.2 - $67.81 $2.75 Million - $3.95 Million
58,231 Added 125.61%
104,591 $5.49 Million
Q1 2021

Apr 28, 2021

BUY
$30.93 - $59.48 $1.43 Million - $2.76 Million
46,360 New
46,360 $2.58 Million

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.59B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Comerica Bank Portfolio

Follow Comerica Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.